See What HealthDay Can Do For You
Contact Us

November 2007 Briefing - Ophthalmology

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for November 2007. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Bevacizumab Shows Promise for Eye Disorder

MONDAY, Nov. 19 (HealthDay News) -- Patients with subfoveal idiopathic choroidal neovascularization showed marked improvements in visual acuity when treated with intravitreal bevacizumab, according to the results of a study published in the November issue of the Archives of Ophthalmology.

Abstract
Full Text

FDA Seizes Potentially Harmful Eyelash Product

MONDAY, Nov. 19 (HealthDay News) -- At the request of the U.S. Food and Drug Administration, U.S. Marshals seized over 12,000 tubes of Age Intervention Eyelash this week, valued at over $2 million, due to concerns that the unapproved, drug-containing cosmetic could lead to decreased vision in some users.

More Information

Early Examination Can Predict Retinopathy of Prematurity

MONDAY, Nov. 19 (HealthDay News) -- Eye examinations on preterm babies revealed that those who went on to develop retinopathy of prematurity in infancy had significantly larger retinal vessel diameter at 31 to 34 weeks' post-conception age, according to a report published in the November issue of the Archives of Ophthalmology.

Abstract
Full Text (subscription or payment may be required)

Ophthalmic Surgical Errors Are Rare

FRIDAY, Nov. 16 (HealthDay News) -- Although surgical confusions are rare in ophthalmic surgery, they can have serious consequences for all parties concerned and preventive measures need active support from the profession, researchers report in the November issue of the Archives of Ophthalmology.

Abstract
Full Text (subscription or payment may be required)

Ranibizumab Combats Macular Degeneration

THURSDAY, Nov. 15 (HealthDay News) -- In patients with neovascular age-related macular degeneration, ranibizumab improves patient-reported visual function, according to the results of a study published in the November issue of the Archives of Ophthalmology.

Abstract
Full Text (subscription or payment may be required)

Basic Eye Care Improves Elders' Quality of Life

THURSDAY, Nov. 15 (HealthDay News) -- Elderly nursing home residents who are given even basic eye care services, such as spectacles to correct refractive error, have improved quality of life and less depressive symptoms, researchers report in the November issue of the Archives of Ophthalmology.

Abstract
Full Text (subscription or payment may be required)

Fenofibrate May Lower Retinopathy Risk in Diabetics

TUESDAY, Nov. 6 (HealthDay News) -- Treating individuals with type 2 diabetes with fenofibrate may reduce the progression of diabetic retinopathy, though this effect does not appear to be related to fenofibrate's lipid-lowering effects, according to study findings published online Nov. 6 in the The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.